Citrate coordination complex of an orally-delivered beta-lactamase inhibitor and uses thereof
US-12559509-B1 · Feb 24, 2026 · US
Venatorx Pharmaceuticals Inc holds 93 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 93 |
| Recent patents | 15 |
| First publication | May 26, 2015 |
| Latest publication | Feb 24, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12559509-B1 · Feb 24, 2026 · US
US-12544395-B2 · Feb 10, 2026 · US
US-2025320235-A1 · Oct 16, 2025 · US
US-2025236632-A1 · Jul 24, 2025 · US
US-2025228882-A1 · Jul 17, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12559509-B1 · Feb 24, 2026 · US
US-12544395-B2 · Feb 10, 2026 · US
US-2025320235-A1 · Oct 16, 2025 · US
US-2025236632-A1 · Jul 24, 2025 · US
US-2025228882-A1 · Jul 17, 2025 · US
Most common classification codes in this portfolio.
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 91 |
| Human Necessities | 88 |
| Cross-Sectional Technologies | 35 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.